Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
19.53
+0.13 (0.67%)
At close: Feb 13, 2026, 4:00 PM EST
19.30
-0.23 (-1.18%)
After-hours: Feb 13, 2026, 7:05 PM EST
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $989.63 million as of February 13, 2026. Its market cap has increased by 108.12% in one year.
Market Cap
989.63M
Enterprise Value
701.52M
1-Year Change
108.12%
Ranking
Category
Stock Price
$19.53
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $989.63M, an increase of 33.61%. That is a compound annual growth rate of 2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 989.60M | 4.38% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.04B |
| Sana Biotechnology | 1.03B |
| Iovance Biotherapeutics | 1.02B |
| Ventyx Biosciences | 1.00B |
| Evommune | 995.22M |
| ORIC Pharmaceuticals | 972.92M |
| Palvella Therapeutics | 965.15M |
| Phathom Pharmaceuticals | 941.10M |